Ignite Creation Date:
2024-05-06 @ 3:03 AM
Last Modification Date:
2024-10-26 @ 11:27 AM
Study NCT ID:
NCT02196857
Status:
COMPLETED
Last Update Posted:
2020-01-14
First Post:
2014-07-18
Brief Title:
Sorafenib Plus 5-Azacitidine Initial Therapy of Patients With Acute Myeloid Leukemia AML and High Risk Myelodysplastic Syndrome MS With FLT3-ITD Mutation
Sponsor:
Organization:
MD Anderson Cancer Center